3 Opiate receptors: Enkephalins and endorphins
References (118)
- et al.
Endorphins in chronic pain. Differences in CSF endorphin levels between organic and psychogenic pain syndromes
Pain
(1978) - et al.
Naloxone reversal of ischaemic neurological deficits in man
Lancet
(1981) Functional and anatomical segregation of hypothalamic opiate receptors involved in prolactin and growth hormone secretion in cynomolgus monkeys
Life Sciences
(1981)- et al.
Effects of naloxone, morphine and methionine enkephalin on serum prolactin, luteinizing hormone, follicle stimulating hormone, thyroid stimulating hormone and growth hormone
Life Sciences
(1977) - et al.
Acupuncture in heroin addicts: changes in Met-enkephalin and β-endorphin in blood and cerebrospinal fluid
Lancet
(1979) - et al.
Isolation of human Met-enkephalin and two groups of putative precursors (2K-Pro-Met-enkephalin) from an adrenal medullary tumour
Biochemical and Biophysical Research Communications
(1980) - et al.
Changes in pituitary hormone levels induced by Met-enkephalin in man — the role of dopamine
Life Sciences
(1981) - et al.
Naloxone in shock
Lancet
(1980) - et al.
Effect of naloxone in a previously undescribed hypothalamic syndrome
Lancet
(1980) - et al.
Regional distribution of methionine enkephalin and substance P-like immunoreactivity in normal human brain and in Huntington's disease
Brain Research
(1980)
Subarachnoid injection of salmon calcitonin induces analgesia in man
European Journal of Pharmacology
(1982)
The influence of naloxone on barbiturate anaesthesia and toxicity in the rat
Life Sciences
(1977)
Analgesic actions of chronic high levels of endogenous neuropeptides in rats bearing the Mt T-F4 tumor
Life Sciences
(1980)
Inhibition of vasopressin release by an opiate peptide in man
Lancet
(1980)
β-endorphin in human cerebrospinal fluid
Lancet
(1978)
Sensitivity to enkephalin as a cause of non-insulin dependent diabetes
Lancet
(1979)
The mechanism of placebo analgesia
Lancet
(1978)
Naloxone: non-steroidal treatment for post-menopausal flushing
Lancet
(1979)
Co-ordinate synthesis of corticotrophins and endorphins by mouse pituitary tumour cells
Journal of Biological Chemistry
(1978)
Failure of naloxone to influence physiological growth hormone and prolactin secretion
Brain Research
(1979)
β-endorphin: effects on respiratory regulation
Life Sciences
(1978)
Pressor effect of naloxone in septic shock
Lancet
(1981)
Enkephalin-like immunoreactivity in the human gastrointestinal tract
Lancet
(1977)
Antagonism of stimulation produced analgesia by naloxone, a narcotic antagonist
Science
(1976)
Enkephalin-like material elevated in ventricular cerebrospinal fluid of pain patients after analgetic focal stimulation
Science
(1978)
Circulating human pituitary proy-melanotropin enhances the adrenal response to ACTH
Nature
(1981)
Stress endorphins and psychosis: a hypothesis
Enddrphins and acupuncture analgesia
Chinese Medical Journal
(1980)
Opiate antagonist reverses the cardiovascular effects of inhalational anaesthesia
Nature
(1979)
Intravenous naloxone in acute respiratory failure
British Medical Journal
(1982)
Corticotropin, lipotropin, and β-endorphin production by a human non-pituitary tumour in culture. Evidence for a common precursor
Characterisation of lipotropin, corticotropin and β-endorphin immunoreactive materials secreted in vitro by a human pituitary adenoma responsible for a case of Nelson's syndrome
Journal of Clinical Endocrinology and Metabolism
(1979)
Simultaneous assay of immunoreactive β-lipotropin, γ-lipotropin and β-endorphin in plasma of normal human subjects, patients with ACTH/lipotropin hypersecretion syndromes and patients undergoing chronic haemodialysis
Journal of Clinical Investigation
(1981)
Effects of naloxone on prolactin and cortisol in normal women
Lung tumours and ACTH production
Clinical Endocrinology
(1977)
Inhibition of vasopressin secretion by a Metenkephalins
Hyper-endorphin syndrome in a child with necrotising encephalomyelopathy
New England Journal of Medicine
(1980)
Multiple opiate receptors: different regional distribution in the brain and differential binding of opiates and opioid peptides
Molecular Pharmacology
(1979)
Dynorphin is a specific endogenous ligand of the kappa opioid receptor
Science
(1982)
Endorphins and ventilatory control
New England Journal of Medicine
(1981)
Opiate inhibition of peptide release from the neurohumoral terminals of hypothalamic neurones
Nature
(1979)
Neuroendocrine correlates of the endorphins and enkephalins
Met-enkephalin circulates in human plasma
Nature
(1980)
Increased β-endorphin but not Met-enkephalin levels in human cerebrospinal fluid after acupuncture for recurrent pain
Lancet
(1980)
Enkephalin precursors in human adrenal medulla and adrenal medullary tumours
Primary structure of the human Met- and Leu-enkephalin precursor and its mRNA
Nature
(1982)
Decreased content of immunoreactive enkephalin-like peptide in peripheral tissues of spontaneously hypertensive rats
Nature
(1979)
β-endorphin and Met-enkephalins: their distribution, modulation by estrogens and haloperidol, and role in neuroendocrine control
Endogenous opiates block dopamine inhibition of prolactin secretion in vitro
Nature
(1979)
Experimental endotoxin shock: the pathophysiological function of endorphins and treatment with opiate antagonists
Journal of Infectious Diseases
(1980)
Cited by (49)
Characterization of the receptor binding residues of kisspeptins by positional scanning using peptide photoaffinity probes
2013, Bioorganic and Medicinal Chemistry LettersRole of aromatase enzyme in the psychosessual orientation
2010, Quaderni Italiani di PsichiatriaEndogenous kappa-opioid receptor systems inhibit hyperalgesia associated with localized peripheral inflammation
2008, PainCitation Excerpt :The effects of pharmacological KOPr blockade were examined using the selective KOPr antagonist, norBNI [9] (NIDA Drug Supply, Bethesda, MD, USA). Previous studies have shown that acute norBNI administration results in the long-lasting (⩾3 weeks) blockade of KOPr [20,26,69]. Since MOPr mediated actions of norBNI have been reported during the first 4 h after its administration, a 24-h pretreatment interval was employed [4,15].
Characterization of zebrafish proenkephalin reveals novel opioid sequences
2003, Molecular Brain Research
Copyright © 1983 Published by Elsevier Ltd.